5th Jan 2010 16:33
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.
On 31 December 2009, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary shares and American Depository Shares (ADSs) in the Company through the annual reinvestment of dividends paid throughout 2009:
GlaxoSmithKline Non-Executive Directors Automatic Share Award and Elected Share Award - Annual Dividend Reinvestment
|
Non-Executive Director |
No. of Ordinary Shares |
Average Price (£) |
No. of ADSs |
Average Price ($) |
|
Sir Christopher Gent |
1,822.44 |
13.25 |
||
|
Prof Sir Roy Anderson |
151.12 |
13.25 |
||
|
Dr Stephanie Burns |
158.38 |
42.40 |
||
|
Mr Lawrence Culp |
717.14 |
42.40 |
||
|
Sir Crispin Davis |
1,501.48 |
13.25 |
||
|
Sir Deryck Maughan |
628.85 |
42.40 |
||
|
Mr James Murdoch |
2.13 |
13.25 |
||
|
Dr Daniel Podolsky |
263.63 |
42.40 |
||
|
Mr Tom de Swaan |
277.24 |
13.25 |
||
|
Sir Robert Wilson |
424.27 |
13.25 |
The Company and the Non-Executive Directors were informed of these allocations on 4 January 2010.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
S M Bicknell
Company Secretary
5 January 2010
Related Shares:
Glaxosmithkline